Used filter(s): 439 items found

  • Remove all filters
  • Search all: Baseball

ASDA Annual report 2000-2001 (Australia)

5 Oct 2001

AUSTRALIAN SPORTS DRUG AGENCY 2000-01 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Contents
CHAIRMAN’S SUMMARY 7
HIGHLIGHTS 12
BOARD 16
ORGANISATIONAL OVERVIEW 20
INCREASING THE SCOPE OF 21
DRUG TESTING
National Drug Testing Program 22
International Drug Testing Activity 24
DESIGNING AND DELIVERING EDUCATION AND INFORMATION SERVICES 25
Drugs in Sport Information 26
Supporting True Champions 27
EPO Testing 28
BUILDING STRONG ANTI-DOPING SYSTEMS 29
National Anti-Doping Systems 30
International Anti-Doping Systems 30
Drug Testing Management Infrastructure 32
INVESTING IN OUR PEOPLE 35
Post Sydney 2000 Games Workshop 36
Learning and Development Strategy 36
Employment Framework 36
Equal Employment and Opportunity 37
Occupational Health and Safety 37
CORPORATE GOVERNANCE 39
Legislative and Regulatory Requirements 40
Corporate Governance Practices 41
Senior Management Team Review 42
Managing Financial and
Material Resources 42
AUSTRALIAN SPORTS DRUG MEDICAL ADVISORY COMMITTEE (ASDMAC) 45
Functions 46
Therapeutic Approvals for Banned Substances 46
Members 46
Process (Approvals) 47
Achievements 48
Trends Internationally 49
Resources 49
GLOSSARY 51
APPENDICES 53
Appendix A Drug Testing for 2000-2001 54
Appendix B Register of Notifiable Events 63
Appendix C Entries on Register of Notifiable Events from Previous Years where 65
Outcomes were to be Advised
Appendix D Summary of Product Distribution and Usage 65
Appendix E International Anti-Doping Arrangements and Drug Testing agreements 66
Appendix F Powers of the Minister under the ASDA Act 70
Appendix G The Objects, Functions and Powers of the Agency as Specified in 71
the ASDA Act
Appendix H Resources for Outcome 1 73
Appendix I Strategic Plan Performance Outcomes Summary 74
Appendix J Financial Statements 78
Appendix K Office of Independent Observer 123
Appendix L Office of Independent Observer: Pre-Games ASDA Audit 126
Appendix M Report on Reiterer’s Allegations concerning the Australian Sports Drug 128
Agency’s Drug Testing Program
Appendix N ASDMAC Functions (excerpt from ASDA Regulations) 140
Appendix O ASDMAC Member Profiles 141
Appendix P ASDMAC Approvals by Sport Since Inception to June 22, 2001 142
INDEX 145
FIGURES
Figure 1: ASDA corporate structure
Figure 2: Athletes believe they will be tested in next 12 months
Figure 3: Athletes perceive deterrent effect from ASDA programs
Figure 4: External client satisfaction with ASDA services
Figure 5: Clients’ perceptions of ASDA resources and educational services
Figure 6: IADA quality standard for doping control
Figure 7: Employment locations of staff
Figure 8: Staff employment by classification and gender
ACRONYMS
AOC Australian Olympic Committee
ASC Australian Sports Commission
ASDA Australian Sports Drug Agency
ABS ASDA Business System
CCES Canadian Centre for Ethics in Sport
DCO Doping Control Officer
DFSC Drug Free Sport Consortium
EPO Erythropoietin
IADA International Anti-Doping Arrangement
IOC International Olympic Committee
IPT International Project Team
ISDC International Standard for Doping Control
ISF international sports federations
ISO International Standards Organisation
ISO/PAS International Standards Organisation Publicly Available Standard
NIF Norwegian Olympic Committee and Confederation of Sports, Department of Ethics,
Sports Medicine and Anti-Doping
NSO national sporting organisation
SOCOG Sydney Organising Committee for the Olympic Games
USADA United States Anti-Doping Agency
WADA World Anti-Doping Agency

ASDA Annual report 2001-2002 (Australia)

4 Oct 2002

AUSTRALIAN SPORTS DRUG AGENCY 2001-02 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Contents
Chairperson's Summary 7
2001-2002 Highlights 11
Australia's Anti-Doping Framework 15
Organisational Overview 17
ASDA at a Glance 18
Corporate Governance 18
ASDA Corporate Structure 25
Deterrence 27
Daig Testing 28
Education 32
Research 36
International Response 37
Facilitating Harmonised International Responses 38
Representing Australia Internationally 40
Business Improvement , 43
Effective Corporate Governance 44
Responding to Business Opportunities 45
Employing Best Practice Business 45
Community Service Obligations 46
People 47
Developing Staff Potential 48
Attracting and Retaining Staff 48
Learning and Development 50
Australian Sports Drug Medical Advisory Committee (ASDMAC) 51
Responsibilities. 52
ASDMAC Members 52
Approvals Process 54
Activities 55
International Trends 55
Funding 56
Glossary 57
Appendices 59
Appendix A - Powers of die Minister under the ASDA Act 60
Appendix B - The Objects, Functions and Powers of the Agency as Specified in die ASDA Act 61
Appendix C - Portfolio Budget Statements Outcomes and Outputs Performance Summary 63
Appendix D - Resources for Portfolio Budget Statements Outcome 1 64
Appendix E - 2001-2005 Strategic Plan 65
Appendix F - Strategic Plan Performance Outcomes Summary for 2001-2002 66
Appendix G - Financial Statements 67
Appendix H - Council of Europe Anti-Doping Convention's Monitoring Group compliance Report 117
Appendix I - Drug Testing for 2001-2002 120
Appendix J - Register of Notifiable Events 131
Appendix K - Entries on Register of Notifiable Eventsfrom Previous Years where Outcomes were to be advised 134
Appendix L - International List of Incidences 135
Appendix M - International Anti-Doping Arrangements and Drug Testing Agreements 136
Appendix N - Australian Sports Drug Medical Advisory Committee Functions 138
Appendix O - Australian Sports Drug Medical Advisory Committee Approvals 139
Index 141
Figures
Figure 1: Australia's Anti-Doping Framework
Figure 2: ASDA Board Details as at 30 June 2002
Figure 3: ASDA Audit Committee Details as at 30 June 2002
Figure 4: ASDA Staff by Gender
Figure 5: ASDA Staff by Location
Figure 6: ASDA Corporate Structure
Figure 7: ASDA Drug Testing Numbers
Figure 8: Government-Funded No-Advance-Notice & Blood Testing Target vs Completed Tests
Figure 9: Percentage of Clients Satisfied with ASDA services
Figure 10: Access to A5DA Education Services
Figure li t ASDA Performance against People Key Performance indicators

ASDA Annual report 2002-2003 (Australia)

1 Oct 2003

AUSTRALIAN SPORTS DRUG AGENCY 2002-03 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Contents
Figures vi
Acronyms vi
Chairperson’s report 01
ASDA snapshot: 2002–2003 05
ASDA in Australia’s anti-doping framework 08
ASDA’s corporate structure 08
Deterrence 09
Drug testing 10
Education 14
Research 18
Reducing the supply of banned drugs 19
International response 21
Facilitating harmonised international response 22
Representing Australia internationally 24
Business improvement 27
Effective corporate governance 28
Responding to business opportunities 29
Employing best practice 30
Managing community service obligations 30
People 31
Developing staff potential 32
Learning and development 33
Attracting and retaining staff 33
Corporate governance 35
Australian Sports Drug Medical Advisory Committee (ASDMAC) 43
Glossary 47
Appendices 49
Appendix A: Drug testing statistics 2002–2003 50
Appendix B: Register of Notifiable Events (RNE) 63
Appendix C: List of International Incidences (LII) 65
Appendix D: Entries on RNE and LII from previous years where outcomes
were to be advised 66
Appendix E: International anti-doping arrangements and drug-testing agreements 67
Appendix F: Financial statements 69
Appendix G: Powers of the Minister under the ASDA Act 111
Appendix H: The objects, functions and powers of the agency as specified in the
ASDA Act 113
Appendix I: Portfolio budget statements performance summary 114
Appendix J: Resources for portfolio budget statements 115
Appendix K: 2001–2005 ASDA Strategic Plan 116
Appendix L: ASDA Strategic Plan performance outcomes 2002–2003 117
Appendix M: ASDMAC functions 118
Appendix N: ASDMAC approvals by sport 2002–2003. 119
Index 121
CHAIRPERSON’S SUMMARY > ASDA ANNUAL REPORT 02:03 > PAGE V
Figures
Figure 1: Australia’s anti-doping framework 8
Figure 2: ASDA’s corporate structure 8
Figure 3: Register of notifiable events trends 1998 to 200 12
Figure 4: ASDA’s client engagement 14
Figure 5: Awareness of ASDA’s services 16
Figure 6: ASDA products distributed 17
Figure 7: Satisfaction with ASDA’s services 17
Figure 8: Effectiveness of ASDA’s international relationships 24
Figure 9: ASDA’s corporate governance — 2002 versus 2003 28
Figure 10: ASDA Board details as at 30 June 2003 36
Figure 11: ASDA Audit Committee details as at 30 June 2003 .38
Figure 12: ASDA staff per program statistics 40
Figure 13: ASDA staff per location statistics 40
Figure 14: Comparison of ASDA staffing levels 40
Figure 15: ASDMAC funding breakdown 46

ASDA Annual report 2003-2004 (Australia)

15 Oct 2003

AUSTRALIAN SPORTS DRUG AGENCY 2003-04 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Table of contents
Table of contents iv
Figures 1
Acronyms 2
About this report 3
Chairperson’s message 5
ASDA snapshot: 2003-04 10
Organisational overview 12
Australia’s anti-doping framework 14
ASDA’s corporate structure 14
Deterrence 16
Drug testing 17
Education and information 24
Implementing effictive anti-doping policies 29
Research 31
Obtaining information to enhance ASDA’s deterrence program 31
International response 34
Facilitating a harmonised international response to doping 34
Representing Australia internationally 36
Business improvement 40
Effective corporate governance 40
Responding to business opportunities 43
Employing best practice 44
Managing community service obligations 45
People 48
Developing staff potential 48
Learning and development 49
Attracting and retaining staff 50
31165 ASDA ANNUAL REPORT 3 22/11/04 4:23 PM Page iv
TABLE OF CONTENTS ASDA ANNUAL REPORT 03:04 PAGE V
ASDA’s Corporate governance 54
The ASDA Board 54
Audit Committee 57
Senior management staff 57
Management committees 58
Staffing overview 58
Strategic and operational plans 58
Reporting compliance 58
Legislative and regulatory requirements 59
Ministerial directions 59
Ecologically sustainable development and environmental performance 59
Equal employment and opportunity 60
Ethical standards 60
Occupational health and safety (OH&S) 61
Discretionary grants 61
Freedom of information (FOI) 61
Risk management and fraud control 62
Social justice and equity 62
Provision of information 62
Commonwealth disability strategy 62
Australian Government Branding 62
Australian Sports Drug Medical Advisory Committee 64
Therapeutic Use Exemption (TUE) approvals
for the legitimate use of prohibited substances 64
ASDMAC members 64
ASDMAC’s achievements 65
ASDMAC’s TUE approval process 66
International TUE trends 67
ASDMAC resources 67
Glossary 70
Appendices 72
Appendix A: ASDA Strategic Plan performance outcomes 2003-04 72
Appendix B: Drug testing statistics 2003-04 73
Appendix C: Register of Notifiable Events (RNE) 86
Appendix D: List of International Incidences (LII) 88
Appendix E: Entries on RNE and LII from previous years where
outcomes were to be advised 89
Appendix F: International anti-doping arrangements and drug testing agreements 90
Appendix G: Financial statements 93
Appendix H: 2001-05 ASDA Strategic Plan 137
Appendix I: Powers of the Minister under the ASDA Act 138
Appendix J: The objects, functions and powers of the Agency as specified in the ASDA Act 139
Appendix K: Portfolio Budget Statements performance summary 141
Appendix L: Summary of Portfolio Budget Statements by outcome 142
Appendix M: ASDMAC functions (excerpt from ASDA Regulations 1999) 143
Appendix N: ASDMAC TUE applications by sport 2003-04 144
Index 148
Figures
Figure 1: Australia’s anti-doping framework
Figure 2: ASDA’s corporate structure
Figure 3: Deterrent effect of ASDA’s programs 2000-04
Figure 4: Adverse drug test result trends 1998-2004
Figure 5: Client awareness of ASDA’s education services
Figure 6: Distribution of ASDA’s education resources
Figure 7: ASDA’s client engagement
Figure 8: ASDA’s corporate governance assessment ratings 2002-03 versus 2003-04
Figure 9: ASDA staff survey satisfaction ratings 1998-2003
Figure 10: ASDA Board details as at 30 June 2004
Figure 11: ASDA Audit Committee details as at 30 June 2004
Figure 12: ASDMAC’s budget 2003-04

ASDA Annual report 2004-2005 (Australia)

15 Oct 2005

AUSTRALIAN SPORTS DRUG AGENCY 2004-05 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Table of contents iv
Figures vi
Acronyms vii
About this report ix
Chairperson’s message 1
Acting Chief Executive report 3
ASDA snapshot: 2004–05 8
Outcome and output structure 9
2004–05 ASDA highlights 10
2005–06 outlook 11
Australia’s anti-doping framework 12
ASDA’s corporate structure 13
Deterrence 16
Drug testing 17
Key projects 23
Education, communication and advocacy services 24
International response 36
Facilitating international consistency 36
Representing Australia internationally 38
Business improvement 46
Effective corporate governance 46
Contracting and purchasing 50
Responding to business opportunities 51
Employing best practice 51
People 56
Developing staff potential 56
Attracting and retaining staff 58
Corporate governance 64
The ASDA Board 64
Audit Committee 67
Senior management staff 67
Management committees 68
Reporting compliance 68
Australian Sports Drug Medical Advisory Committee 76
Glossary 80
Appendices 82
Appendix A: ASDA Strategic Plan performance outcomes 2004–05 82
Appendix B: Drug testing statistics 2004–05 83
Appendix C: ASDA drug tests completed - 1989 to 30 June 2005 93
Appendix D: Drug testing statistics 2003–04 — Amendments to 2003–04
Annual Report Appendix B 94
Appendix E: Register of Notifiable Events (RNE) 2004–05 95
Appendix F: List of International Incidences (LII) 97
Appendix G: Entries on RNE and LII from previous years where outcomes were
to be advised 98
Appendix H: International anti-doping arrangements and drug testing agreements 99
Appendix I: Financial statements 101
Appendix J: 2001–05 ASDA Strategic Plan 143
Appendix K: Powers of the Minister under the ASDA Act 144
Appendix L: The objects, functions and powers of the Agency as specified
in the ASDA Act 145
Appendix M: Portfolio Budget Statements performance summary 147
Appendix N: Summary of Portfolio Budget Statements by outcome 148
Appendix O: ASDMAC functions (excerpt from ASDA Regulations 1999) 149
Appendix P: ASDMAC approvals by sport July 1 2004 to 30 June 2005 150
Compliance index 154
Index 155
Figures
Figure 1: ASDA’s outcome and output structure
Figure 2: Australia’s anti-doping framework
Figure 3: ASDA’s corporate structure
Figure 4: Deterrent effect of ASDA’s programs 2000 to 2005
Figure 5: ASDA drug tests completed 1989 to 2005
Figure 6: Register of Notifiable Events trends 1998 to 2005
Figure 7: Distribution of ASDA’s education resources
Figure 8: ASDA’s client engagement
Figure 9: ASDA staff survey satisfaction ratings 1998 to 2004
Figure 10: Gender composition of ASDA permanent staff
Figure 11: ASDA Board details as at 30 June 2005
Figure 12: ASDA Audit Committee details as at 30 June 2005
Figure 13: ASDMAC’s budget 2004–05

ASADA Annual Report 2005-2006 (Australia)

26 Sep 2006

AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2005-06 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1833-8976

Table of Contents iv
Figures vi
Acronyms vii
About this report ix
Overview 1
Chair’s message 2
Organisational overview 4
ASDA Snapshot 2005–06 4
Outcome and output structure 5
ASADA Snapshot: 2005–06 6
2005–06 ASADA highlights 9
2006–07 ASADA outlook 9
ASDA’s Organisational Structure 10
ASADA’s Organisational Structure 11
Australia’s Anti-Doping Framework 12
Performance review 13
Performance reports 14
Resources for Outcome 14
Outcome 1 14
Output 1.1 Drug testing program 15
Detection 15
Enforcement 22
Compliance 22
Deterrence 23
Key Projects 23
Output 1.2 Education, communication and advocacy services 26
Education and communication 27
Advocacy 33
Management Accountability 41
Corporate Governance 42
Senior management committees 43
Risk management 46
External scrutiny 49
Management of Human Resources 51
Financials 57
Discretionary grants 58
Asset management 58
Purchasing 59
Consultants 59
Competitive tendering and contracting 60
Compliance requirements 61
Australian Sports Drug Agency 63
Corporate Governance 64
Financial management 66
Contracting and purchasing 67
People 68
Australian Sports Drug Medical Advisory Committee 73
Financial Statements 77
Appendices 157
Appendix A: Doping Control statistics 1989 to 30 June 2006 158
Appendix B: Register of Notifiable Events (RNE) 2005–06 159
Appendix C: List of International Incidences (LII) 2005–06 162
Appendix D: Register of Findings (RoF) 2005–06 163
Appendix E: International anti-doping arrangements and Doping Control agreements 164
Appendix F: The functions, powers and delegations of ASADA in accordance with
the ASADA Act 2006 166
Appendix G: Powers of the Minister under the ASADA Act 168
Appendix H: The objects, functions and powers of ASDA as specified in the ASDA Act 169
Appendix I: Powers of the Minister under the ASDA Act 171
Appendix J: ASADA Staffing Statistics as at 30 June 2006 172
Appendix K: ASDA Staffing Statistics as at 13 March 2006 174
Appendix L: Freedom of Information 176
Appendix M: 2001-05 ASDA Strategy Plan 177
Appendix N: ASDMAC Functions (excerpt from ASADA Regulations) 178
Appendix O: ASDMAC Approvals by Sport July 1 2005 to 30 June 2006 179
Glossary 183
Compliance Index 185
Index 188
Figures
Figure 1: ASDA’s outcome and output structure 5
Figure 2: Changes to the outcome and output structure 2006–07 8
Figure 3: ASADA’s outcome and output structure 2006–07 8
Figure 4: ASDA’S organisational structure 10
Figure 5: ASADA’S organisational structure 11
Figure 6: Australia’s anti-doping framework 12
Figure 7: Resources for outcome 14
Figure 8: Output 1.1 performance measures 15
Figure 9: ASADA’s Doping Control statistics for 2005–06 17
Figure 10: Register of Notifiable Events and Register of Findings trends 1998 to 2006 21
Figure 11: Output 1.2 performance measures 26
Figure 12: Distribution of education and communication products and services 30
Figure 13: ASADA Member details as at 30 June 2006 44
Figure 14: Expenditure on new and existing contracts 60
Figure 15: Service provider contracts over $100,000 60
Figure 16: Media advertising agencies 61
Figure 17: ASDA Board details as at 13 March 2006 64
Figure 18: ASDA Audit Commitee details as at 13 March 2006 66
Figure 19: ASDMAC budget 2005–06 76

ASADA Annual Report 2006-2007 (Australia)

21 Sep 2007

AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2006-07 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1833-8976

Table of contents
Letter of transmittal iii
About this report iv
Overview 1
Message from the Chair 2
Organisation overview 7
Snapshot for 2006–07 7
Highlights for 2006–07 9
Outlook for 2007–08 9
Report on Performance 13
Performance reports 14
Outcome 1 14
Output 1.1 Deterrence Program 15
Deterrence 17
Education and communication 17
Key projects 22
Output 1.2 Detection Program 26
Output 1.3 Enforcement Program 31
Enforcement 32
Compliance 33
Advocacy 34
Management and accountability 41
Corporate governance 42
Overview 42
Corporate/operational planning and performance management 43
Corporate/operational planning and performance management 43
ASADA members 43
Senior management committees 47
Risk management 48
Ethical standards 50
Social justice and equity impacts 50
Audit and investigations 50
Financial management 51
External scrutiny 52
Management of human resources 53
Financial information 61
Summary of our financial performance 62
Discretionary grants 62
Asset management 63
Purchasing 63
Consultants 63
Ecologically sustainable development and environmental performance 65
Australian Sports Drug Medical Advisory Committee 67
Overview 68
Therapeutic approvals for banned substances 68
ASDMAC members 68
Achievements 69
International trends 70
Resources 71
Financial statements 73
Appendixes 113
Appendix A: Doping control statistics 1997–98 to 2006–07 114
Appendix B: Register of Findings 2006–07 115
Appendix C: International anti-doping and doping control 119
Appendix D: Powers of the minister to give directions to ASADA 121
Appendix E: ASADA’s functions, powers and delegations 122
Appendix F: Staffing statistics at 30 June 2007 125
Appendix G: Freedom of information 127
Appendix H: Australian Sports Drug Medical Advisory Committee – functions 130
Appendix I: Australian Sports Drug Medical Advisory Committee – therapeutic
use exemptions granted 130
List of abbreviations 133
Glossary 137
Compliance index 139
Index 142
TABLE OF CONTENTS ASADA Annual Report 2006:07
vii
Tables
Table 1: ASADA’s outcome and output structure 2006–07 8
Table 2: Resources for Outcome 1 14
Table 3: Output 1.1 Performance measures 15
Table 4: Output 1.2 Performance measures 26
Table 5: ASADA’s doping control statistics 2006–07 27
Table 6: Doping control facts and figures 2006–07 29
Table 7: Output 1.3 Performance measures 31
Table 8: ASADA member details at 30 June 2007 44
Table 9: Expenditure on new and existing contracts 2006–07 64
Table 10: Service provider contracts over $100,000 65
Table 11: ASDMAC members 69
Table 12: Breakdown of ASDMAC’s budget for 2006–07 71
Table 13: Doping control statistics 114
Table 14: Quarter 1 – Register of Findings 115
Table 15: Quarter 2 – Register of Findings 116
Table 16: Quarter 3 – Register of Findings 117
Table 17: Quarter 4 – Register of Findings 118
Table 18: Government-to-government arrangements 119
Table 19: National anti-doping organisation to national anti-doping organisation 120
Table 20: Full-time and part-time staff at 30 June 2007 125
Table 21: Staff by classification groups and location at 30 June 2007 125
Table 22: SES staff at 30 June 2007 125
Table 23: Staff in equal employment opportunity groups at 30 June 2007 125
Table 24: Salary ranges of employees 126
Table 25: Number of staff on AWAs or certified agreement 126
Table 26: Performance payments 2005–06, paid in 2006–07 126
Table 27: Therapeutic use exemption applications 2006–07 130
Table 28: Substances approved for therapeutic use 132
Figures
Figure 1: Our organisational structure 10
Figure 2: Australia’s anti-doping framework 11

ASADA Annual Report 2007-2008 (Australia)

19 Sep 2008

AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2007-08 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1833-8976

Table of contents
Letter of transmittal iii
Guide to this report iv
Overview 1
Message from the Chair 2
About us 6
Snapshot of ASADA 6
Highlights from 2007–08 10
Outlook for 2008–09 10
Report on performance 13
Report on performance 14
Outcome 1 15
Output 1.1 – Deterrence Program 16
Deterrence 18
Output 1.2 – Detection Program 28
Detection 29
Output 1.3 – Enforcement Program 33
Enforcement 34
Management and accountability 37
Corporate governance 38
External scrutiny 48
Management of human resources 49
Financial information 55
Summary of our financial performance 56
Discretionary grants 56
Asset management 56
Purchasing 57
Engagement of consultants and contractors 57
Financial statements 60
Australian Sports Drug Medical Advisory Committee 103
Appendixes 109
Appendix A: Doping control statistics 1997–98 to 2007–08 110
Appendix B: Publicly announced anti-doping rule violations 2007–08 111
Appendix C: International anti-doping and doping control 114
Appendix D: Powers of the minister to give directions to ASADA 115
Appendix E: ASADA’s functions, powers and delegations 116
Appendix F: Staffing statistics at 30 June 2008 118
Appendix G: Occupational health and safety 121
Appendix H: Advertising and market research 122
Appendix I: Ecologically sustainable development and environmental performance 123
Appendix J: Freedom of information 124
Appendix K: Australian Sports Drug Medical Advisory Committee – functions 125
Appendix L: Australian Sports Drug Medical Advisory Committee – therapeutic use exemptions granted 127
List of abbreviations and glossary 131
Indexes 135
Tables
Table 1: Resources for Outcome 1 15
Table 2: Output 1.1 performance measures 16
Table 3: Education activities during 2007–08 20
Table 4: Output 1.2 performance measures 28
Table 5: Anti-doping tests conducted by ASADA in 2007–08 30
Table 6: Doping control facts and figures 2007–08 30
Table 7: Output 1.3 performance measures 33
Table 8: ASADA member details at 30 June 2008 40
Table 9: ASADA members’ attendance at Anti-Doping Rule Violation
Committee meetings 2007–08 42
Table 10: Expenditure on new and existing consultancy contracts 2007–08 57
Table 11: Consultancy service let during 2007–08 of $10,000 or more 58
Table 12: ASDMAC Members 105
Table 13 ASDMAC budget 2007–08 107
Table 14: Doping control statistics 110
Table 15: Publicly announced anti-doping rule violations 111
Table 16: Entries on the Register of Findings 2006–07 where the outcome was to be advised 113
Table 17: Government to government arrangements 114
Table 18: Full and part time staff at 30 June 2008 118
Table 19: Staff by classification groups and location at 30 June 2008 118
Table 20: SES staff at 30 June 2008 118
Table 21: Staff in equal employment opportunity groups at 30 June 2008 119
Table 22: Salary ranges of employees 119
Table 23: Number of staff on AWAs or certified agreement 120
Table 24: Performance payments 2006–07, paid in 2007–08 120
Table 25: Advertising and market research 122
Table 26: Therapeutic use exemption applications 2007–08 127
Table 27: Substances approved for therapeutic use 129
Figures
Figure 1: Organisational structure at 30 June 2008 8
Figure 2: Australia’s anti-doping framework 9
Figure 3: ASADA’s outcome and output structure 2007–08 14
Figure 4: Number of athletes recording anti-doping rule violations 35

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin